(Q44258543)

1 December 2017

title

Electrophysiology and pharmacology of cardiac arrhythmias. VIII. Cardiac effects of diphenylhydantoin. A (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1155329

27 August 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

17 October 2023

author name string

A. L. Wit

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1155329

27 August 2022

M. R. Rosen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1155329

27 August 2022

B. F. Hoffman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1155329

27 August 2022

language of work or name

English

0 references

publication date

1 August 1975

1 reference

full work available at URL

1 December 2017

https://api.elsevier.com/content/article/PII:0002870375901301?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

https://api.elsevier.com/content/article/PII:0002870375901301?httpAccept=text/plain

17 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

17 October 2023

published in

American Heart Journal

1 reference

1 December 2017

volume

90

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

265-272

1 reference

Effects of diphenylhydantoin sodium (dilantin sodium) and phenobarbital sodium upon ectopic ventricular tachycardia in acute myocardial infarction

1 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The effect of diphenylhydantoin sodium (dilantin), procaine hydrochloride, procaine amide hydrochloride, and quinidine hydrochloride upon ouabain-induced ventricular tachycardia in unanesthetized dogs

17 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Effectiveness of Several Antifibrillary Drugs in the Hypothermic Dog

17 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The effect of diphenylhydantoin (Dilantin) sodium on atrial flutter and fibrillation provoked by focal application of a conitine or delphinine

17 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The Electrophysiological Properties of Diphenylhydantoin Sodium as Compared to Procaine Amide in the Normal and Digitalis-Intoxicated Heart

17 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The use of diphenylhydantoin (dilantin) sodium in the treatment of ventricular tachycardia

17 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic Effects

17 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The current status of diphenylhydantoin in heart disease

17 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Diphenylhydantoin in cardiac arrhythmias

17 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The clinical use of diphenylhydantoin (dilantin) in the treatment and prevention of cardiac arrhythmias

17 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Digitalis toxicity: drug interactions promoting toxicity and the management of toxicity

17 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Treatment of cardiac arrhythmias with phenytoin

17 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Diphenylhydantoin in the Prevention of Recurring Ventricular Tachycardia

17 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart Disease

17 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Phenytoin after recovery from myocardial infarction

17 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Intravenous diphenylhydantoin sodium (Dilantin) in cardiac arrhythmias

17 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Newer Drugs in the Treatment of Cardiac Arrhythmia

17 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Digitalis toxicity. Treatment with diphenylhydantoin

17 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Phenytoin in post-operative cardiac arrhythmias

17 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Biochemical and genetic factors regulating dilantin metabolism in man.

17 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Inadequate serum levels after intramuscular administration of diphenylhydantoin

17 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.

17 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Some effects of diphenylhydantoin and propranolol on the cardiovascular system

17 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Studies on the absorption, distribution, fate and excretion of 4-C14-labeled diphenylhydantoin

17 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The metabolic fate of diphenylhydantoin in the dog, rat and man

17 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Some Causes of Ineffectiveness of Diphenylhydantoin

17 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction.

17 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation

17 October 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

A method for estimation of plasma diphenylhydantoin concentration

17 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The rate of decline of diphenylhydantoin in human plasma

17 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE

17 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Acute diphenylhydantoin intoxication following halothane anesthesia.

17 October 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY

17 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Some Causes of Ineffectiveness of Diphenylhydantoin

17 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes

17 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

DRUG INTERACTIONS IN MAN. I. LOWERING EFFECT OF PHENOBARBITAL ON PLASMA LEVELS OF BISHYDROXYCOUMARIN (DICUMAROL) AND DIPHENYLHYDANTOIN (DILANTIN)

17 October 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The influence of phenobarbital on the half-life of diphenylhydantoin in man

17 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes

17 October 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding

17 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

17 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-8703(75)90130-1

17 October 2023

Identifiers

1 reference

1 December 2017

1 reference